Isomorphic Labs’ Series B financing is the second largest ever raised by a biotech startup. Like the largest one, Isomorphic is also opaque about its drug programs.
The post This TechBio Startup Just Raised $2B Without Disclosing a Single Detail About Its Drugs appeared first on MedCity News.
